It All Adds Up

Sandra Porter says accessing scientific papers from several journals can be costly. At her Discovering Biology in a Digital World blog, Porter outlines personal subscription and individual article access costs for multiple journals, finding that prices vary widely among them. In comments to this post, David Robert Grimes says that because science journals don't provide the content of proofing, their per-article prices are especially difficult to swallow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.